CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics's Leverage Ratio

ATRA's quarterly Leverage Ratio and Total Liabilities, Equity growth




ATRA Leverage Ratio (Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
Y / Y Equity Change -48.67 % -35.35 % 90.51 % 95.7 % 104.62 %
Y / Y Total Liabilities Change 24.8 % 47.86 % -5.95 % 52.01 % 45.79 %
Leverage Ratio MRQ 0.18 0.14 0.1 0.09 0.07
Overall Ranking # # # # #
Seq. Equity Change -18.19 % -16.21 % -15.93 % -10.93 % 3.03 %
Seq. Total Liabilities Change 2.63 % 20.79 % -6.4 % 7.56 % 21.6 %



Leverage Ratio second quarter 2019 Comment
Due to net new borrowings of 2.63%, Leverage Ratio detoriated to 0.18, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2019, 32 other companies have achieved lower Leverage Ratio than Atara Biotherapeutics. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ATRA Customers?
Leverage Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 33
Healthcare Sector # 127
Overall Market # 310


Leverage Ratio Statistics
High Average Low
0.2 0.07 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics's Equity $ 232 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics's Total Liabilities $ 42 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Equity
Armata Pharmaceuticals, Inc.  0.49 $ 11.022  Millions$ 22.630  Millions
Eiger Biopharmaceuticals, Inc.  0.49 $ 42.884  Millions$ 88.079  Millions
Trovagene, Inc.  0.48 $ 4.204  Millions$ 8.848  Millions
Opiant Pharmaceuticals, Inc.  0.44 $ 8.762  Millions$ 20.063  Millions
Myriad Genetics Inc  0.44 $ 473.800  Millions$ 1,088.900  Millions
Pluristem Therapeutics Inc  0.43 $ 9.489  Millions$ 21.821  Millions
Cellular Biomedicine Group, Inc.  0.43 $ 35.510  Millions$ 82.177  Millions
Eloxx Pharmaceuticals, Inc.  0.43 $ 23.815  Millions$ 55.224  Millions
Voyager Therapeutics, Inc.  0.43 $ 50.461  Millions$ 118.404  Millions
Cellect Biotechnology Ltd.  0.42 $ 9.241  Millions$ 21.908  Millions
Vericel Corp  0.42 $ 37.284  Millions$ 88.542  Millions
Allena Pharmaceuticals, Inc.  0.40 $ 15.154  Millions$ 37.673  Millions
Akers Biosciences, Inc.  0.37 $ 1.618  Millions$ 4.314  Millions
Cv Sciences, Inc.  0.37 $ 12.624  Millions$ 34.288  Millions
Assembly Biosciences, Inc.  0.37 $ 63.950  Millions$ 174.707  Millions
Mateon Therapeutics Inc  0.36 $ 2.043  Millions$ 5.616  Millions
Vermillion, Inc.  0.36 $ 4.786  Millions$ 13.366  Millions
Crispr Therapeutics Ag  0.34 $ 126.562  Millions$ 367.683  Millions
Denali Therapeutics Inc.  0.34 $ 162.431  Millions$ 475.173  Millions
Vitality Biopharma, Inc.  0.34 $ 1.248  Millions$ 3.670  Millions
Pdl Biopharma, Inc.  0.34 $ 225.235  Millions$ 665.424  Millions
Heska Corp  0.32 $ 39.922  Millions$ 122.922  Millions
Cohbar, Inc.  0.30 $ 4.169  Millions$ 13.743  Millions
Eyenovia, Inc.  0.30 $ 2.285  Millions$ 7.618  Millions
Celldex Therapeutics, Inc.  0.30 $ 32.618  Millions$ 109.626  Millions
Strongbridge Biopharma Plc  0.29 $ 26.832  Millions$ 91.289  Millions
Scpharmaceuticals Inc.  0.29 $ 18.455  Millions$ 63.469  Millions
Adaptimmune Therapeutics Plc  0.28 $ 52.530  Millions$ 186.991  Millions
Pds Biotechnology Corp  0.28 $ 5.708  Millions$ 20.606  Millions
Proteostasis Therapeutics, Inc.  0.28 $ 22.660  Millions$ 81.985  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SQN's Profile

Stock Price

SQN's Financials

Business Description

Fundamentals

Charts & Quotes

SQN's News

Suppliers

SQN's Competitors

Customers & Markets

Economic Indicators

SQN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071